{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:25:30Z","timestamp":1793701530702,"version":"4.5.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1245\/s10434-020-09106-0","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T18:03:50Z","timestamp":1599156230000},"page":"1798-1807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy"],"prefix":"10.1245","volume":"28","author":[{"given":"Yoichi","family":"Hamai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Emi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Ibuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manato","family":"Ohsawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Hirohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuno","family":"Nishibuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuki","family":"Imano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"9106_CR1","doi-asserted-by":"publisher","first-page":"681692","DOI":"10.1016\/S1470-2045(11)70142-5","volume":"12","author":"KM Sjoquist","year":"2011","unstructured":"Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681692.","journal-title":"Lancet Oncol."},{"key":"9106_CR2","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074\u201384.","journal-title":"N Engl J Med."},{"key":"9106_CR3","unstructured":"Leng X, He W, Yang H, et al. Prognostic impact of postoperative lymph node metastases after neoadjuvant chemoradiotherapy for locally advanced squamous cell carcinoma of esophagus: from the results of NEOCRTEC5010, a randomized multicenter study. Ann Surg. 2019."},{"key":"9106_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1200\/JCO.2013.51.2186","volume":"32","author":"V Oppedijk","year":"2014","unstructured":"Oppedijk V, van der Gaast A, van Lanschot JJ, et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol. 2014;32:385\u201391.","journal-title":"J Clin Oncol."},{"key":"9106_CR5","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s00268-017-4283-1","volume":"42","author":"Y Hamai","year":"2018","unstructured":"Hamai Y, Hihara J, Emi M, et al. Evaluation of prognostic factors for esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy followed by surgery. World J Surg. 2018;42:1496\u2013505.","journal-title":"World J Surg."},{"key":"9106_CR6","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.21873\/anticanres.13259","volume":"39","author":"Y Hamai","year":"2019","unstructured":"Hamai Y, Emi M, Ibuki Y, et al. Early recurrence and cancer death after trimodal therapy for esophageal squamous cell carcinoma. Anticancer Res. 2019;39:1433\u201340.","journal-title":"Anticancer Res."},{"key":"9106_CR7","first-page":"5639","volume":"37","author":"Y Hamai","year":"2017","unstructured":"Hamai Y, Hihara J, Emi M, et al. Effects of neoadjuvant chemoradiotherapy on pathological TNM stage and their prognostic significance for surgically-treated esophageal squamous cell carcinoma. Anticancer Res. 2017;37:5639\u201346.","journal-title":"Anticancer Res."},{"key":"9106_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649\u201355.","journal-title":"Am J Clin Oncol."},{"key":"9106_CR9","volume-title":"International Union Against Cancer (UICC): TNM Classification of Malignant Tumours (7th edition)","year":"2009","unstructured":"Sobin L, Gospodarowicz M, Wittekind C, eds. International Union Against Cancer (UICC): TNM classification of malignant tumours. 7th ed. Wiley: New York; 2009."},{"key":"9106_CR10","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1148\/rg.346130079","volume":"34","author":"SJ Hong","year":"2014","unstructured":"Hong SJ, Kim TJ, Nam KB, et al. New TNM staging system for esophageal cancer: what chest radiologists need to know. Radiographics. 2014;34:1722\u201340.","journal-title":"Radiographics."},{"key":"9106_CR11","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.athoracsur.2016.04.011","volume":"102","author":"Y Hamai","year":"2016","unstructured":"Hamai Y, Hihara J, Emi M, et al. Ability of fluorine-18 fluorodeoxyglucose positron emission tomography to predict outcomes of neoadjuvant chemoradiotherapy followed by surgical treatment for esophageal squamous cell carcinoma. Ann Thorac Surg. 2016;102:1132\u201339.","journal-title":"Ann Thorac Surg."},{"key":"9106_CR12","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00280-012-1853-7","volume":"69","author":"M Emi","year":"2012","unstructured":"Emi M, Hihara J, Hamai Y, et al. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer. Cancer Chemother Pharmacol. 2012;69:1499\u2013505.","journal-title":"Cancer Chemother Pharmacol."},{"key":"9106_CR13","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.athoracsur.2015.02.042","volume":"99","author":"Y Hamai","year":"2015","unstructured":"Hamai Y, Hihara J, Emi M, et al. Results of neoadjuvant chemoradiotherapy with docetaxel and 5-fluorouracil followed by esophagectomy to treat locally advanced esophageal cancer. Ann Thorac Surg. 2015;99:1887\u201393.","journal-title":"Ann Thorac Surg."},{"key":"9106_CR14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/jrr\/rry047","volume":"59","author":"Y Murakami","year":"2018","unstructured":"Murakami Y, Hamai Y, Emi M, et al. Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma. J Radiat Res. 2018;59:616\u201324.","journal-title":"J Radiat Res."},{"key":"9106_CR15","doi-asserted-by":"publisher","unstructured":"Hamai Y, Emi M, Ibuki Y, et al. Predictions of pathological features and recurrence based on FDG-PET findings of esophageal squamous cell carcinoma after trimodal therapy. Ann Surg Oncol. 2020. https:\/\/doi.org\/10.1245\/s10434-020-08609-0.","DOI":"10.1245\/s10434-020-08609-0"},{"key":"9106_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10388-016-0556-2","volume":"14","author":"Japan Esophageal Society","year":"2017","unstructured":"Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part II and III. Esophagus. 2017;14:37\u201365.","journal-title":"Esophagus."},{"key":"9106_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-016-0551-7","volume":"14","author":"Japan Esophageal Society","year":"2017","unstructured":"Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus. 2017;14:1\u201336.","journal-title":"Esophagus."},{"key":"9106_CR18","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1245\/s10434-019-07498-2","volume":"26","author":"J Aoyama","year":"2019","unstructured":"Aoyama J, Kawakubo H, Mayanagi S, et al. Discrepancy between the clinical and final pathological findings of lymph node metastasis in superficial esophageal cancer. Ann Surg Oncol. 2019;26:2874\u201381.","journal-title":"Ann Surg Oncol."},{"key":"9106_CR19","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/SLA.0000000000001557","volume":"264","author":"Y Akutsu","year":"2016","unstructured":"Akutsu Y, Kato K, Igaki H, et al. The Prevalence of overall and initial lymph node metastases in clinical T1N0 thoracic esophageal cancer: from the results of JCOG0502, a prospective multicenter study. Ann Surg. 2016;264:1009\u201315.","journal-title":"Ann Surg."},{"key":"9106_CR20","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1245\/s10434-011-1753-9","volume":"18","author":"C Castoro","year":"2011","unstructured":"Castoro C, Scarpa M, Cagol M, et al. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Ann Surg Oncol. 2011;18:3743\u201354.","journal-title":"Ann Surg Oncol."},{"key":"9106_CR21","doi-asserted-by":"crossref","unstructured":"Hagens ERC, K\u00fcnzli HT, van Rijswijk AS, et al. Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective study. Surg Endosc. 2019;17.","DOI":"10.1007\/s00464-019-07205-y"},{"key":"9106_CR22","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1080\/0284186X.2019.1648865","volume":"58","author":"WPM Dijksterhuis","year":"2019","unstructured":"Dijksterhuis WPM, Hulshoff JB, van Dullemen HM, et al. Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients. Acta Oncol. 2019;58:1640\u201347.","journal-title":"Acta Oncol."},{"key":"9106_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.5090\/kjtcs.2019.52.5.353","volume":"52","author":"SY Kim","year":"2019","unstructured":"Kim SY, Park S, Park IK, Kim YT, Kang CH. Lymph node status after neoadjuvant chemoradiation therapy for esophageal cancer according to radiation field coverage. Korean J Thorac Cardiovasc Surg. 2019;52:353\u20139.","journal-title":"Korean J Thorac Cardiovasc Surg."},{"key":"9106_CR24","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1245\/s10434-019-07158-5","volume":"26","author":"Y Hamai","year":"2019","unstructured":"Hamai Y, Hihara J, Emi M, et al. Clinical significance of 18F-Fluorodeoxyglucose-positron emission tomography-positive lymph nodes to outcomes of trimodal therapy for esophageal squamous cell carcinoma. Ann Surg Oncol. 2019;26:1869\u201378.","journal-title":"Ann Surg Oncol."},{"key":"9106_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.surg.2018.01.011","volume":"164","author":"Y Hamai","year":"2018","unstructured":"Hamai Y, Hihara J, Emi M, et al. Preoperative prediction of a pathologic complete response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy. Surgery. 2018;164:40\u20138.","journal-title":"Surgery."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09106-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-09106-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09106-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T19:28:38Z","timestamp":1630697318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-09106-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["9106"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-09106-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}